Total Funding
32
1
Total FundingConvertible Note raised
Growth Score
-2 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1150406
Hapten Sciences develops novel products to improve the health and well-being of people around the world.
Raymond J. Hage: President, CEO, and FounderPast Role: Novavax, SVP Commercial Operations
Gary Prosterman: Chairman
About the Company
Hapten Sciences operates as a privately-held biopharmaceutical company based in Memphis, Tennessee. The company’s mission is to identify and efficiently develop novel, early-stage products that will significantly contribute to the health and well being of people around the world.
